臼井亮太

Last Update: 2020/07/01 11:29:05

Name(Kanji/Kana/Abecedarium Latinum): 臼井亮太/ウスイリョウタ/Usui, Ryota
Primary Affiliation(Org1/Job title): Kyoto University Hospital/Program-Specific Assistant Professor
ORCID ID: https://orcid.org/0000-0002-4641-0158
researchmap URL: https://researchmap.jp/ryota_u

Published Papers

Author	Author(Japanese)	Author(English)	Title	Title(Japanese)	Title(English)	Bibliography	Bibliography(Japanese)	Bibliography(English)	Publication date	Refereed paper	Language	Publishing type	Disclose
Ryota Usui, Daisuke Yabe, Muhammad Fauzi, Hisanori Goto, Ainur Botagarova, Shinsuke Tokumoto, Hisato Tatsuoka, Yumiko Tahara, Shizuka Kobayashi, Toshiya Manabe, Yoshihiro Baba, Tomohiro Kurosaki, Pedro Luis Herrera, Masahito Ogura, Kazuaki Nagashima, Nobuya Inagaki	Usui R, Yabe D, Fauzi M, Goto H, Botagarova A, Tokumoto S, Tatsuoka H, Tahara Y, Kobayashi S, Manabe T, Baba Y, Kurosaki T, Herrera PL, Ogura M, Nagashima K, Inagaki N	Ryota Usui, Daisuke Yabe, Muhammad Fauzi, Hisanori Goto, Ainur Botagarova, Shinsuke Tokumoto, Hisato Tatsuoka, Yumiko Tahara, Shizuka Kobayashi, Toshiya Manabe, Yoshihiro Baba, Tomohiro Kurosaki, Pedro Luis Herrera, Masahito Ogura, Kazuaki Nagashima, Nobuya Inagaki	GPR40 activation initiates store-operated Ca2+ entry and potentiates insulin secretion via the IP3R1/STIM1/Orai1 pathway in pancreatic β-cells.	GPR40 activation initiates store-operated Ca<sup>2+</sup> entry and potentiates insulin secretion via the IP3R1/STIM1/Orai1 pathway in pancreatic β-cells.	GPR40 activation initiates store-operated Ca2+ entry and potentiates insulin secretion via the IP3R1/STIM1/Orai1 pathway in pancreatic β-cells.	Scientific reports, 9, 1, 15562-15562	Scientific reports, 9, 1, 15562-15562	Scientific reports, 9, 1, 15562-15562	2019/10/29	Refereed	English		Disclose to all
Liu Y, Harashima SI, Wang Y, Suzuki K, Tokumoto S, Usui R, Tatsuoka H, Tanaka D, Yabe D, Harada N, Hayashi Y, Inagaki N	Liu Y, Harashima SI, Wang Y, Suzuki K, Tokumoto S, Usui R, Tatsuoka H, Tanaka D, Yabe D, Harada N, Hayashi Y, Inagaki N	Liu Y, Harashima SI, Wang Y, Suzuki K, Tokumoto S, Usui R, Tatsuoka H, Tanaka D, Yabe D, Harada N, Hayashi Y, Inagaki N	Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion.	Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion.	Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion.	FASEB journal : official publication of the Federation of American Societies for Experimental Biology, fj201801783RR	FASEB journal : official publication of the Federation of American Societies for Experimental Biology, fj201801783RR	FASEB journal : official publication of the Federation of American Societies for Experimental Biology, fj201801783RR	2019/02	Refereed			Disclose to all
Ryota Usui, Daisuke Yabe, Yutaka Seino	Ryota Usui, Daisuke Yabe, Yutaka Seino	Ryota Usui, Daisuke Yabe, Yutaka Seino	Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity	Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity	Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity	Journal of Diabetes Investigation	Journal of Diabetes Investigation	Journal of Diabetes Investigation	2019/02	Refereed			Disclose to all
Kuwata H, Okamoto S, Seino Yus, Murotani K, Tatsuoka H, Usui R, Hamamoto Y, Kurose T, Seino Yut, Yabe D	Kuwata H, Okamoto S, Seino Yus, Murotani K, Tatsuoka H, Usui R, Hamamoto Y, Kurose T, Seino Yut, Yabe D	Kuwata H, Okamoto S, Seino Yus, Murotani K, Tatsuoka H, Usui R, Hamamoto Y, Kurose T, Seino Yut, Yabe D	Relationship between deterioration of HbA1c-lowering effects in DPP-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes	Relationship between deterioration of HbA1c-lowering effects in DPP-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes	Relationship between deterioration of HbA1c-lowering effects in DPP-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes	J Diabetes Investig, 9, 5, 1153-1158	J Diabetes Investig, 9, 5, 1153-1158	J Diabetes Investig, 9, 5, 1153-1158	2018/09	Refereed	English	Research paper(scientific journal)	Disclose to all
Hitoshi Kuwata, Saki Okamoto, Yusuke Seino, Kenta Murotani, Hisato Tatsuoka, Ryota Usui, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe	Hitoshi Kuwata, Saki Okamoto, Yusuke Seino, Kenta Murotani, Hisato Tatsuoka, Ryota Usui, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe	Hitoshi Kuwata, Saki Okamoto, Yusuke Seino, Kenta Murotani, Hisato Tatsuoka, Ryota Usui, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe	Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes.	Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes.	Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes.	Journal of diabetes investigation, 9, 5, 1153-1158	Journal of diabetes investigation, 9, 5, 1153-1158	Journal of diabetes investigation, 9, 5, 1153-1158	2018/09	Refereed	English		Disclose to all
Usui R, Sakuramachi Y, Seino Yus, Murotani K, Kuwata H, Tatsuoka H, Hamamoto Y, Kurose T, Seino Yut, Yabe D	Usui R, Sakuramachi Y, Seino Yus, Murotani K, Kuwata H, Tatsuoka H, Hamamoto Y, Kurose T, Seino Yut, Yabe D	Usui R, Sakuramachi Y, Seino Yus, Murotani K, Kuwata H, Tatsuoka H, Hamamoto Y, Kurose T, Seino Yut, Yabe D	Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target one year after initiation.	Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target one year after initiation.	Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target one year after initiation.	J Diabetes Investig, 9, 4, 822-830	J Diabetes Investig, 9, 4, 822-830	J Diabetes Investig, 9, 4, 822-830	2018/07	Refereed	English	Research paper(scientific journal)	Disclose to all
Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe	Usui R, Sakuramachi Y, Seino Y, Murotani K, Kuwata H, Tatsuoka H, Hamamoto Y, Kurose T, Seino Y, Yabe D	Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe	Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation.	Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation	Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation.	Journal of diabetes investigation, 9, 4, 822-830	Journal of Diabetes Investigation, 9, 4, 822-830	Journal of diabetes investigation, 9, 4, 822-830	2018/07	Refereed	English		Disclose to all
Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe	Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe	Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe	Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation.	Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after init	Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation.	Journal of diabetes investigation, 9, 4, 981-983	Journal of Diabetes Investigation, 9, 4, 981-983	Journal of diabetes investigation, 9, 4, 981-983	2018/07	Refereed	English		Disclose to all
Yu Wang, Shin-ichi Harashima, Yanyan Liu, Ryota Usui, Nobuya Inagaki	Yu Wang, Shin-ichi Harashima, Yanyan Liu, Ryota Usui, Nobuya Inagaki	Yu Wang, Shin-ichi Harashima, Yanyan Liu, Ryota Usui, Nobuya Inagaki	Sphingosine kinase 1-interacting protein is a novel regulator of glucose-stimulated insulin secretion	Sphingosine kinase 1-interacting protein is a novel regulator of glucose-stimulated insulin secretion	Sphingosine kinase 1-interacting protein is a novel regulator of glucose-stimulated insulin secretion	SCIENTIFIC REPORTS, 7, 1	SCIENTIFIC REPORTS, 7, 1	SCIENTIFIC REPORTS, 7, 1	2017/04	Refereed	English	Research paper(scientific journal)	Disclose to all
Kasane Ogura, Masahito Ogura, Toshihiko Shoji, Yuichi Sato, Yumiko Tahara, Gen Yamano, Hiroki Sato, Kazu Sugizaki, Naotaka Fujita, Hisato Tatsuoka, Ryota Usui, Eri Muka, Shimpei Fujimoto, Nobuya Inagaki, Kazuaki Nagashima	Kasane Ogura, Masahito Ogura, Toshihiko Shoji, Yuichi Sato, Yumiko Tahara, Gen Yamano, Hiroki Sato, Kazu Sugizaki, Naotaka Fujita, Hisato Tatsuoka, Ryota Usui, Eri Muka, Shimpei Fujimoto, Nobuya Inagaki, Kazuaki Nagashima	Kasane Ogura, Masahito Ogura, Toshihiko Shoji, Yuichi Sato, Yumiko Tahara, Gen Yamano, Hiroki Sato, Kazu Sugizaki, Naotaka Fujita, Hisato Tatsuoka, Ryota Usui, Eri Muka, Shimpei Fujimoto, Nobuya Inagaki, Kazuaki Nagashima	Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice	Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice	Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice	JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 64, 46, 8857-8865	JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 64, 46, 8857-8865	JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 64, 46, 8857-8865	2016/11	Refereed	English	Research paper(scientific journal)	Disclose to all
Hiroki Sato, Kazuaki Nagashima, Masahito Ogura, Yuichi Sato, Yumiko Tahara, Kasane Ogura, Gen Yamano, Kazu Sugizaki, Naotaka Fujita, Hisato Tatsuoka, Ryota Usui, Eri Mukai, Shimpei Fujimoto, Nobuya Inagaki	Sato H, Nagashima K, Ogura M, Sato Y, Tahara Y, Ogura K, Yamano G, Sugizaki K, Fujita N, Tatsuoka H, Usui R, Mukai E, Fujimoto S, Inagaki N	Hiroki Sato, Kazuaki Nagashima, Masahito Ogura, Yuichi Sato, Yumiko Tahara, Kasane Ogura, Gen Yamano, Kazu Sugizaki, Naotaka Fujita, Hisato Tatsuoka, Ryota Usui, Eri Mukai, Shimpei Fujimoto, Nobuya Inagaki	Src regulates insulin secretion and glucose metabolism by influencing subcellular localization of glucokinase in pancreatic -cells	Src regulates insulin secretion and glucose metabolism by influencing subcellular localization of glucokinase in pancreatic β-cells	Src regulates insulin secretion and glucose metabolism by influencing subcellular localization of glucokinase in pancreatic -cells	JOURNAL OF DIABETES INVESTIGATION, 7, 2, 171-178	Journal of Diabetes Investigation, 7, 2, 171-178	JOURNAL OF DIABETES INVESTIGATION, 7, 2, 171-178	2016/03	Refereed	English	Research paper(scientific journal)	Disclose to all
Ryota Usui, Daisuke Yabe, Hitoshi Kuwata, Kenta Murotani, Takeshi Kurose, Yutaka Seino	Usui R, Yabe D, Kuwata H, Murotani K, Kurose T, Seino Y	Ryota Usui, Daisuke Yabe, Hitoshi Kuwata, Kenta Murotani, Takeshi Kurose, Yutaka Seino	Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining beta-cell function and achievement of HbA1c target one year after initiation	Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining β-cell function and achievement of HbA1c target one year after initiation	Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining beta-cell function and achievement of HbA1c target one year after initiation	JOURNAL OF DIABETES AND ITS COMPLICATIONS, 29, 8, 1203-1210	Journal of Diabetes and its Complications, 29, 8, 1203-1210	JOURNAL OF DIABETES AND ITS COMPLICATIONS, 29, 8, 1203-1210	2015/11	Refereed	English	Research paper(scientific journal)	Disclose to all
Daisuke Yabe, Hitoshi Kuwata, Ryota Usui, Takeshi Kurose, Yutaka Seino	Daisuke Yabe, Hitoshi Kuwata, Ryota Usui, Takeshi Kurose, Yutaka Seino	Daisuke Yabe, Hitoshi Kuwata, Ryota Usui, Takeshi Kurose, Yutaka Seino	Glucagon-like peptide-1 receptor agonist therapeutics for total diabetes management: assessment of composite end-points	Glucagon-like peptide-1 receptor agonist therapeutics for total diabetes management: assessment of composite end-points	Glucagon-like peptide-1 receptor agonist therapeutics for total diabetes management: assessment of composite end-points	CURRENT MEDICAL RESEARCH AND OPINION, 31, 7, 1267-1270	CURRENT MEDICAL RESEARCH AND OPINION, 31, 7, 1267-1270	CURRENT MEDICAL RESEARCH AND OPINION, 31, 7, 1267-1270	2015/07	Refereed	English		Disclose to all
安原章浩, 臼井亮太, 岩崎真宏, 桑田仁司, 渡邊好胤, 表孝徳, 矢部大介, 北谷直美, 古宮俊幸, 黒瀬健	安原章浩, 臼井亮太, 岩崎真宏, 桑田仁司, 渡邊好胤, 表孝徳, 矢部大介, 北谷直美, 古宮俊幸, 黒瀬健		腎機能低下２型糖尿病患者におけるリラグルチドの有効性、安全性および食事療法との関連性の検討	腎機能低下２型糖尿病患者におけるリラグルチドの有効性、安全性および食事療法との関連性の検討		日本病態栄養学会学会誌, 17, 3, 367-375	日本病態栄養学会学会誌, 17, 3, 367-375	, 17, 3, 367-375	2014	Refereed			Disclose to all
Ryota Usui, Daisuke Yabe, Hitoshi Kuwata, Shuichi Fujiwara, Koin Watanabe, Takanori Hyo, Akihiro Yasuhara, Masahiro Iwasaki, Naomi Kitatani, Kyoko Kuwabara, Kayo Yokota, Takeshi Kurose, Yutaka Seino	Usui R, Yabe D, Kuwata H, Fujiwara S, Watanabe K, Hyo T, Yasuhara A, Iwasaki M, Kitatani N, Kuwabara K, Yokota K, Kurose T, Seino Y	Ryota Usui, Daisuke Yabe, Hitoshi Kuwata, Shuichi Fujiwara, Koin Watanabe, Takanori Hyo, Akihiro Yasuhara, Masahiro Iwasaki, Naomi Kitatani, Kyoko Kuwabara, Kayo Yokota, Takeshi Kurose, Yutaka Seino	Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced beta-cell function	Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β-cell function	Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced beta-cell function	JOURNAL OF DIABETES INVESTIGATION, 4, 6, 585-594	Journal of Diabetes Investigation, 4, 6, 585-594	JOURNAL OF DIABETES INVESTIGATION, 4, 6, 585-594	2013/11	Refereed	English	Research paper(scientific journal)	Disclose to all
Daisuke Yabe, Mariyo Rokutan, Yoshiyuki Miura, Izumi Komoto, Ryota Usui, Hitoshi Kuwata, Koin Watanabe, Takanori Hyo, Takeshi Kurose, Terumi Nagamatsu, Shinobu Shimizu, Jun Kawai, Masayuki Imamura, Yutaka Seino	Yabe D, Rokutan M, Miura Y, Komoto I, Usui R, Kuwata H, Watanabe K, Hyo T, Kurose T, Nagamatsu T, Shimizu S, Kawai J, Imamura M, Seino Y	Daisuke Yabe, Mariyo Rokutan, Yoshiyuki Miura, Izumi Komoto, Ryota Usui, Hitoshi Kuwata, Koin Watanabe, Takanori Hyo, Takeshi Kurose, Terumi Nagamatsu, Shinobu Shimizu, Jun Kawai, Masayuki Imamura, Yutaka Seino	Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: Implications for glucagon-like peptide-1 secretion from pancreatic alpha cells in vivo	Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: Implications for glucagon-like peptide-1 secretion from pancreatic α cells in vivo	Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: Implications for glucagon-like peptide-1 secretion from pancreatic alpha cells in vivo	DIABETES RESEARCH AND CLINICAL PRACTICE, 102, 1, E1-E4	Diabetes Research and Clinical Practice, 102, 1, E1-E4	DIABETES RESEARCH AND CLINICAL PRACTICE, 102, 1, E1-E4	2013/10	Refereed	English	Research paper(scientific journal)	Disclose to all
Nakatani K, Kurose T, Watanabe K, Matsumoto M, Fujiwara S, Usui R, Kuwata H, Hyo T, Yabe D, Seino Y	Nakatani K, Kurose T, Watanabe K, Matsumoto M, Fujiwara S, Usui R, Kuwata H, Hyo T, Yabe D, Seino Y	Nakatani K, Kurose T, Watanabe K, Matsumoto M, Fujiwara S, Usui R, Kuwata H, Hyo T, Yabe D, Seino Y	Drug-induced generalized itching erythema in diabetes mellitus receiving dipeptidyl peptidase-IV inhibitors plus metformin	Drug-induced generalized itching erythema in diabetes mellitus receiving dipeptidyl peptidase-IV inhibitors plus metformin	Drug-induced generalized itching erythema in diabetes mellitus receiving dipeptidyl peptidase-IV inhibitors plus metformin	Diabetes Therapy, 3, 1, 14	Diabetes Therapy, 3, 1, 14	Diabetes Therapy, 3, 1, 14	2012/12	Refereed			Disclose to all
Masahiro Iwasaki, Fuminori Hoshian, Tomoko Tsuji, Naoki Hirose, Tomoko Matsumoto, Naomi Kitatani, Kenji Sugawara, Ryota Usui, Hitoshi Kuwata, Kazu Sugizaki, Yuka Kitamoto, Shuichi Fujiwara, Koin Watanabe, Takanori Hyo, Takeshi Kurose, Yutaka Seino, Daisuke Yabe	Masahiro Iwasaki, Fuminori Hoshian, Tomoko Tsuji, Naoki Hirose, Tomoko Matsumoto, Naomi Kitatani, Kenji Sugawara, Ryota Usui, Hitoshi Kuwata, Kazu Sugizaki, Yuka Kitamoto, Shuichi Fujiwara, Koin Watanabe, Takanori Hyo, Takeshi Kurose, Yutaka Seino, Daisuke Yabe	Masahiro Iwasaki, Fuminori Hoshian, Tomoko Tsuji, Naoki Hirose, Tomoko Matsumoto, Naomi Kitatani, Kenji Sugawara, Ryota Usui, Hitoshi Kuwata, Kazu Sugizaki, Yuka Kitamoto, Shuichi Fujiwara, Koin Watanabe, Takanori Hyo, Takeshi Kurose, Yutaka Seino, Daisuke Yabe	Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels	Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels	Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels	JOURNAL OF DIABETES INVESTIGATION, 3, 5, 464-467	JOURNAL OF DIABETES INVESTIGATION, 3, 5, 464-467	JOURNAL OF DIABETES INVESTIGATION, 3, 5, 464-467	2012/10	Refereed	English	Research paper(scientific journal)	Disclose to all
六反麻里代, 矢部大介, 臼井亮太, 菅原健二, 北本友佳, 桑田仁司, 杉崎和, 藤原周一, 渡邊好胤, 表孝徳, 河合潤, 細田洋平, 粟根雅章, 滝吉郎, 舘秀和, 植田孔明, 水野浩, 黒瀬健, 清野裕	六反麻里代, 矢部大介, 臼井亮太, 菅原健二, 北本友佳, 桑田仁司, 杉崎和, 藤原周一, 渡邊好胤, 表孝徳, 河合潤, 細田洋平, 粟根雅章, 滝吉郎, 舘秀和, 植田孔明, 水野浩, 黒瀬健, 清野裕		HbA1c悪化と体重減少を契機に膵癌を含む重複癌が発見された2型糖尿病の一例	HbA1c悪化と体重減少を契機に膵癌を含む重複癌が発見された2型糖尿病の一例		糖尿病, 55, 7, 477-482	糖尿病, 55, 7, 477-482	, 55, 7, 477-482	2012	Refereed			Disclose to all
Rokutan M, Yabe D, Usui R, Sugawara K, Kitamoto Y, Kuwata H, Sugizaki K, Fujiwara S, Watanabe K, Hyo T, Kawai J, Hosoda Y, Awane M, Taki Y, Tachi H, Ueda Y, Mizuno H, Kurose T, Seino Y	Rokutan M, Yabe D, Usui R, Sugawara K, Kitamoto Y, Kuwata H, Sugizaki K, Fujiwara S, Watanabe K, Hyo T, Kawai J, Hosoda Y, Awane M, Taki Y, Tachi H, Ueda Y, Mizuno H, Kurose T, Seino Y	Rokutan M, Yabe D, Usui R, Sugawara K, Kitamoto Y, Kuwata H, Sugizaki K, Fujiwara S, Watanabe K, Hyo T, Kawai J, Hosoda Y, Awane M, Taki Y, Tachi H, Ueda Y, Mizuno H, Kurose T, Seino Y	A case of triple cancer of the pancreas, colon, and peripheral nerve sheath in type 2 diabetes found by progressive body weight loss and deteriorating glycemic control	A case of triple cancer of the pancreas, colon, and peripheral nerve sheath in type 2 diabetes found by progressive body weight loss and deteriorating glycemic control	A case of triple cancer of the pancreas, colon, and peripheral nerve sheath in type 2 diabetes found by progressive body weight loss and deteriorating glycemic control	Journal of the Japan Diabetes Society, 55, 7, 477-482	Journal of the Japan Diabetes Society, 55, 7, 477-482	Journal of the Japan Diabetes Society, 55, 7, 477-482	2012	Refereed			Disclose to all
<< < > >> Title language:

Misc

Author	Author(Japanese)	Author(English)	Title	Title(Japanese)	Title(English)	Bibliography	Bibliography(Japanese)	Bibliography(English)	Publication date	Language	Publishing type	Disclose
劉彦言, 原島伸一, 王宇, 鈴木和代, 徳本信介, 臼井亮太, 龍岡久登, 田中大祐, 矢部大介, 原田範雄, 林良敬, 稲垣暢也	劉彦言, 原島伸一, 王宇, 鈴木和代, 徳本信介, 臼井亮太, 龍岡久登, 田中大祐, 矢部大介, 原田範雄, 林良敬, 稲垣暢也	劉彦言, 原島伸一, 王宇, 鈴木和代, 徳本信介, 臼井亮太, 龍岡久登, 田中大祐, 矢部大介, 原田範雄, 林良敬, 稲垣暢也	Sphingosine kinase 1-interacting proteinはインスリン及びインクレチン分泌の双方の制御因子である	Sphingosine kinase 1-interacting proteinはインスリン及びインクレチン分泌の双方の制御因子である	Sphingosine kinase 1-interacting proteinはインスリン及びインクレチン分泌の双方の制御因子である	日本臨床分子医学会学術総会プログラム・抄録集, 56回, 69-69	日本臨床分子医学会学術総会プログラム・抄録集, 56回, 69-69	日本臨床分子医学会学術総会プログラム・抄録集, 56回, 69-69	2019/04	Japanese		Disclose to all
後藤久典, 臼井亮太, 矢部大介	後藤久典, 臼井亮太, 矢部大介		GLP-1受容体作動薬の心血管・腎イベントリスクに対する効果	GLP-1受容体作動薬の心血管・腎イベントリスクに対する効果		糖尿病の最新治療, 10, 2, 92-98	糖尿病の最新治療, 10, 2, 92-98	, 10, 2, 92-98	2019/02			Disclose to all
矢部大介, 桑田仁司, 岡本紗希, 室谷健太, 清野祐介, 臼井亮太, 龍岡久登, 浜本芳之, 黒瀬健, 清野裕	矢部大介, 桑田仁司, 岡本紗希, 室谷健太, 清野祐介, 臼井亮太, 龍岡久登, 浜本芳之, 黒瀬健, 清野裕	矢部大介, 桑田仁司, 岡本紗希, 室谷健太, 清野祐介, 臼井亮太, 龍岡久登, 浜本芳之, 黒瀬健, 清野裕	DPP-4阻害薬の長期有効性と食習慣日本人2型糖尿病患者におけるメトホルミンとの後ろ向き比較解析	DPP-4阻害薬の長期有効性と食習慣日本人2型糖尿病患者におけるメトホルミンとの後ろ向き比較解析	DPP-4阻害薬の長期有効性と食習慣日本人2型糖尿病患者におけるメトホルミンとの後ろ向き比較解析	日本内分泌学会雑誌, 94, 1, 337-337	日本内分泌学会雑誌, 94, 1, 337-337	日本内分泌学会雑誌, 94, 1, 337-337	2018/04	Japanese		Disclose to all
小倉かさね, 長嶋一昭, 庄司俊彦, 田原裕美子, 杉崎和, 臼井亮太, 龍岡久登, 佐藤雄一, 山野言, 佐藤広規, 小倉雅仁, 稲垣暢也	小倉かさね, 長嶋一昭, 庄司俊彦, 田原裕美子, 杉崎和, 臼井亮太, 龍岡久登, 佐藤雄一, 山野言, 佐藤広規, 小倉雅仁, 稲垣暢也	小倉かさね, 長嶋一昭, 庄司俊彦, 田原裕美子, 杉崎和, 臼井亮太, 龍岡久登, 佐藤雄一, 山野言, 佐藤広規, 小倉雅仁, 稲垣暢也	林檎由来プロシアニジン類の重合度の違いによる抗糖尿病効果とその機序の検討	林檎由来プロシアニジン類の重合度の違いによる抗糖尿病効果とその機序の検討	林檎由来プロシアニジン類の重合度の違いによる抗糖尿病効果とその機序の検討	糖尿病(Web), 59, Suppl, S.333(J‐STAGE)	糖尿病(Web), 59, Suppl, S.333(J‐STAGE)	糖尿病(Web), 59, Suppl, S.333(J‐STAGE)	2016	Japanese		Disclose to all
小倉かさね, 長嶋一昭, 庄司俊彦, 田原裕美子, 山野言, 佐藤広規, 杉崎和, 臼井亮太, 龍岡久登, 小倉雅仁, 稲垣暢也	小倉かさね, 長嶋一昭, 庄司俊彦, 田原裕美子, 山野言, 佐藤広規, 杉崎和, 臼井亮太, 龍岡久登, 小倉雅仁, 稲垣暢也	小倉かさね, 長嶋一昭, 庄司俊彦, 田原裕美子, 山野言, 佐藤広規, 杉崎和, 臼井亮太, 龍岡久登, 小倉雅仁, 稲垣暢也	林檎由来プロシアニジン類の重合度の違いによる抗糖尿病効果の検討	林檎由来プロシアニジン類の重合度の違いによる抗糖尿病効果の検討	林檎由来プロシアニジン類の重合度の違いによる抗糖尿病効果の検討	糖尿病, 58, Supplement 1, S.446	糖尿病, 58, Supplement 1, S.446	糖尿病, 58, Supplement 1, S.446	2015/04/25	Japanese		Disclose to all
小倉かさね, 長嶋一昭, 庄司俊彦, 佐藤雄一, 田原裕美子, 山野言, 佐藤広規, 杉崎和, 臼井亮太, 龍岡久登, 小倉雅仁, 向英里, 藤本新平, 稲垣暢也	小倉かさね, 長嶋一昭, 庄司俊彦, 佐藤雄一, 田原裕美子, 山野言, 佐藤広規, 杉崎和, 臼井亮太, 龍岡久登, 小倉雅仁, 向英里, 藤本新平, 稲垣暢也	小倉かさね, 長嶋一昭, 庄司俊彦, 佐藤雄一, 田原裕美子, 山野言, 佐藤広規, 杉崎和, 臼井亮太, 龍岡久登, 小倉雅仁, 向英里, 藤本新平, 稲垣暢也	林檎由来プロシアニジン類長期投与によるob/obマウスにおけるインスリン抵抗性改善機序の検討	林檎由来プロシアニジン類長期投与によるob/obマウスにおけるインスリン抵抗性改善機序の検討	林檎由来プロシアニジン類長期投与によるob/obマウスにおけるインスリン抵抗性改善機序の検討	日本病態栄養学会誌, 18, Supplement, S.88	日本病態栄養学会誌, 18, Supplement, S.88	日本病態栄養学会誌, 18, Supplement, S.88	2014/12/10	Japanese		Disclose to all
H. Kuwata, D. Yabe, M. Iwasaki, R. Usui, K. Takeshi, Y. Seino	H. Kuwata, D. Yabe, M. Iwasaki, R. Usui, K. Takeshi, Y. Seino	H. Kuwata, D. Yabe, M. Iwasaki, R. Usui, K. Takeshi, Y. Seino	COMPARISON OF FISH OR MEAT INTAKE BEFORE AND AFTER RICE ON POSTPRANDIAL GLUCOSE EXCURSIONS AND INCRETIN SECRETION IN TYPE 2 DIABETES: MEAL-SEQUENCE AS A NOVEL TARGET IN DIETARY THERAPY FOR DIABETES	COMPARISON OF FISH OR MEAT INTAKE BEFORE AND AFTER RICE ON POSTPRANDIAL GLUCOSE EXCURSIONS AND INCRETIN SECRETION IN TYPE 2 DIABETES: MEAL-SEQUENCE AS A NOVEL TARGET IN DIETARY THERAPY FOR DIABETES	COMPARISON OF FISH OR MEAT INTAKE BEFORE AND AFTER RICE ON POSTPRANDIAL GLUCOSE EXCURSIONS AND INCRETIN SECRETION IN TYPE 2 DIABETES: MEAL-SEQUENCE AS A NOVEL TARGET IN DIETARY THERAPY FOR DIABETES	DIABETES RESEARCH AND CLINICAL PRACTICE, 106, S68-S69	DIABETES RESEARCH AND CLINICAL PRACTICE, 106, S68-S69	DIABETES RESEARCH AND CLINICAL PRACTICE, 106, S68-S69	2014/11	English	Research paper, summary (international conference)	Disclose to all
Daisuke Yabe, Hitoshi Kuwata, Masahiro Iwasaki, Ryota Usui, Takeshi Kurose, Yutaka Seino	Daisuke Yabe, Hitoshi Kuwata, Masahiro Iwasaki, Ryota Usui, Takeshi Kurose, Yutaka Seino	Daisuke Yabe, Hitoshi Kuwata, Masahiro Iwasaki, Ryota Usui, Takeshi Kurose, Yutaka Seino	Comparison of Fish or Meat Intake before and after Rice on Postprandial Glucose Excursions and Incretin Secretion in Type 2 Diabetes: Meal-Sequence As a Novel Target in Dietary Therapies for Diabetes	Comparison of Fish or Meat Intake before and after Rice on Postprandial Glucose Excursions and Incretin Secretion in Type 2 Diabetes: Meal-Sequence As a Novel Target in Dietary Therapies for Diabetes	Comparison of Fish or Meat Intake before and after Rice on Postprandial Glucose Excursions and Incretin Secretion in Type 2 Diabetes: Meal-Sequence As a Novel Target in Dietary Therapies for Diabetes	ENDOCRINE REVIEWS, 35, 3	ENDOCRINE REVIEWS, 35, 3	ENDOCRINE REVIEWS, 35, 3	2014/06	English	Research paper, summary (international conference)	Disclose to all
臼井亮太, 矢部大介, 黒瀬健, 清野裕	臼井亮太, 矢部大介, 黒瀬健, 清野裕		GLP-1受容体作動薬はどのような患者に適していますか？	GLP-1受容体作動薬はどのような患者に適していますか？		治療, 96, 6, 988-989	治療, 96, 6, 988-989	, 96, 6, 988-989	2014			Disclose to all
臼井亮太, 清野裕	臼井亮太, 清野裕		長時間作用型GLP-1受容体作動薬（週1回製剤）	長時間作用型GLP-1受容体作動薬（週1回製剤）		糖尿病の最新治療, 5, 1	糖尿病の最新治療, 5, 1	, 5, 1	2013/11			Disclose to all
臼井亮太, 清野裕	臼井亮太, 清野裕		インクレチン関連薬の新薬について―今後，新薬やジェネリックは出てくるのか？	インクレチン関連薬の新薬について―今後，新薬やジェネリックは出てくるのか？		糖尿病診療マスター, 11, 3, 290-293	糖尿病診療マスター, 11, 3, 290-293	, 11, 3, 290-293	2013/04			Disclose to all
藤原周一, 表孝徳, 黒瀬健, 臼井亮太, 菅原健二, 北本友佳, 杉崎和, 桑田仁司, 渡邊好胤, 矢部大介, 清野裕	藤原周一, 表孝徳, 黒瀬健, 臼井亮太, 菅原健二, 北本友佳, 杉崎和, 桑田仁司, 渡邊好胤, 矢部大介, 清野裕	藤原周一, 表孝徳, 黒瀬健, 臼井亮太, 菅原健二, 北本友佳, 杉崎和, 桑田仁司, 渡邊好胤, 矢部大介, 清野裕	糖尿病ケトアシドーシス昏睡で発症した脳膿瘍の1例	糖尿病ケトアシドーシス昏睡で発症した脳膿瘍の1例	糖尿病ケトアシドーシス昏睡で発症した脳膿瘍の1例	糖尿病, 55, 9, 727-727	糖尿病, 55, 9, 727-727	糖尿病, 55, 9, 727-727	2012/09	Japanese		Disclose to all
黒瀬健, 杉崎和, 菅原健二, 桑田仁司, 藤原周一, 北本友佳, 臼井亮太, 渡辺好胤, 表孝徳, 矢部大介, 清野裕	黒瀬健, 杉崎和, 菅原健二, 桑田仁司, 藤原周一, 北本友佳, 臼井亮太, 渡辺好胤, 表孝徳, 矢部大介, 清野裕	黒瀬健, 杉崎和, 菅原健二, 桑田仁司, 藤原周一, 北本友佳, 臼井亮太, 渡辺好胤, 表孝徳, 矢部大介, 清野裕	糖尿病患者におけるFMD測定値に関与する因子の検討	糖尿病患者におけるFMD測定値に関与する因子の検討	糖尿病患者におけるFMD測定値に関与する因子の検討	糖尿病, 55, 9, 731-731	糖尿病, 55, 9, 731-731	糖尿病, 55, 9, 731-731	2012/09	Japanese		Disclose to all
矢部大介, 臼井亮太, 菅原健二, 北本友佳, 杉崎和, 藤原周一, 渡邊好胤, 表孝徳, 安原章浩, 黒瀬健, 清野裕	矢部大介, 臼井亮太, 菅原健二, 北本友佳, 杉崎和, 藤原周一, 渡邊好胤, 表孝徳, 安原章浩, 黒瀬健, 清野裕	矢部大介, 臼井亮太, 菅原健二, 北本友佳, 杉崎和, 藤原周一, 渡邊好胤, 表孝徳, 安原章浩, 黒瀬健, 清野裕	薬物未治療もしくは経口糖尿病薬治療中の2型糖尿病患者へのリラグルチド導入の効果	薬物未治療もしくは経口糖尿病薬治療中の2型糖尿病患者へのリラグルチド導入の効果	薬物未治療もしくは経口糖尿病薬治療中の2型糖尿病患者へのリラグルチド導入の効果	糖尿病, 55, 8, 647-647	糖尿病, 55, 8, 647-647	糖尿病, 55, 8, 647-647	2012/08	Japanese		Disclose to all
桑田仁司, 矢部大介, 臼井亮太, 菅原健二, 北本友佳, 杉崎和, 藤原周一, 渡邊好胤, 表孝徳, 黒瀬健, 清野裕	桑田仁司, 矢部大介, 臼井亮太, 菅原健二, 北本友佳, 杉崎和, 藤原周一, 渡邊好胤, 表孝徳, 黒瀬健, 清野裕	桑田仁司, 矢部大介, 臼井亮太, 菅原健二, 北本友佳, 杉崎和, 藤原周一, 渡邊好胤, 表孝徳, 黒瀬健, 清野裕	日本人2型糖尿病患者のインクレチン分泌パターンの特徴と分泌に影響を与える因子の検索	日本人2型糖尿病患者のインクレチン分泌パターンの特徴と分泌に影響を与える因子の検索	日本人2型糖尿病患者のインクレチン分泌パターンの特徴と分泌に影響を与える因子の検索	糖尿病, 55, 8, 649-649	糖尿病, 55, 8, 649-649	糖尿病, 55, 8, 649-649	2012/08	Japanese		Disclose to all
臼井亮太, 矢部大介, 菅原健二, 北本友佳, 桑田仁司, 杉崎和, 藤原周一, 渡辺好胤, 表孝徳, 黒瀬健, 清野裕	臼井亮太, 矢部大介, 菅原健二, 北本友佳, 桑田仁司, 杉崎和, 藤原周一, 渡辺好胤, 表孝徳, 黒瀬健, 清野裕	臼井亮太, 矢部大介, 菅原健二, 北本友佳, 桑田仁司, 杉崎和, 藤原周一, 渡辺好胤, 表孝徳, 黒瀬健, 清野裕	インスリンからリラグルチドへの変更時の効果及び注意点に関する検討	インスリンからリラグルチドへの変更時の効果及び注意点に関する検討	インスリンからリラグルチドへの変更時の効果及び注意点に関する検討	糖尿病, 55, 8, 656-656	糖尿病, 55, 8, 656-656	糖尿病, 55, 8, 656-656	2012/08	Japanese		Disclose to all
杉崎和, 矢部大介, 臼井亮太, 菅原健二, 北本友佳, 桑田仁司, 藤原周一, 渡邊好胤, 表孝徳, 黒瀬健, 清野裕	杉崎和, 矢部大介, 臼井亮太, 菅原健二, 北本友佳, 桑田仁司, 藤原周一, 渡邊好胤, 表孝徳, 黒瀬健, 清野裕	杉崎和, 矢部大介, 臼井亮太, 菅原健二, 北本友佳, 桑田仁司, 藤原周一, 渡邊好胤, 表孝徳, 黒瀬健, 清野裕	リラグルチド導入による血糖日内変動の改善持続血糖測定(CGM)と1,5-AGによる評価	リラグルチド導入による血糖日内変動の改善持続血糖測定(CGM)と1,5-AGによる評価	リラグルチド導入による血糖日内変動の改善持続血糖測定(CGM)と1,5-AGによる評価	糖尿病, 55, 8, 657-657	糖尿病, 55, 8, 657-657	糖尿病, 55, 8, 657-657	2012/08	Japanese		Disclose to all
臼井亮太, 矢部大介, 菅原健二, 桑田仁司, 藤原周一, 北本友佳, 杉崎和, 渡邊好胤, 表孝徳, 安原章浩, 黒瀬健, 清野裕	臼井亮太, 矢部大介, 菅原健二, 桑田仁司, 藤原周一, 北本友佳, 杉崎和, 渡邊好胤, 表孝徳, 安原章浩, 黒瀬健, 清野裕	臼井亮太, 矢部大介, 菅原健二, 桑田仁司, 藤原周一, 北本友佳, 杉崎和, 渡邊好胤, 表孝徳, 安原章浩, 黒瀬健, 清野裕	インスリンからリラグルチドへの変更時の効果および注意点に関する検討	インスリンからリラグルチドへの変更時の効果および注意点に関する検討	インスリンからリラグルチドへの変更時の効果および注意点に関する検討	糖尿病, 55, Suppl.1, S-95	糖尿病, 55, Suppl.1, S-95	糖尿病, 55, Suppl.1, S-95	2012/04	Japanese		Disclose to all
藤原周一, 矢部大介, 黒瀬健, 菅原健二, 臼井亮太, 北本友佳, 杉崎和, 桑田仁司, 渡邊好胤, 表孝徳, 清野裕	藤原周一, 矢部大介, 黒瀬健, 菅原健二, 臼井亮太, 北本友佳, 杉崎和, 桑田仁司, 渡邊好胤, 表孝徳, 清野裕	藤原周一, 矢部大介, 黒瀬健, 菅原健二, 臼井亮太, 北本友佳, 杉崎和, 桑田仁司, 渡邊好胤, 表孝徳, 清野裕	瞳孔反応を用いた糖尿病神経障害の評価糖尿病自律神経障害早期検出のためのカットオフ値の検討	瞳孔反応を用いた糖尿病神経障害の評価糖尿病自律神経障害早期検出のためのカットオフ値の検討	瞳孔反応を用いた糖尿病神経障害の評価糖尿病自律神経障害早期検出のためのカットオフ値の検討	糖尿病, 55, Suppl.1, S-177	糖尿病, 55, Suppl.1, S-177	糖尿病, 55, Suppl.1, S-177	2012/04	Japanese		Disclose to all
桑田仁司, 臼井亮太, 菅原健二, 北本友佳, 杉崎和, 藤原周一, 渡邊好胤, 表孝徳, 安原章浩, 矢部大介, 黒瀬健, 清野裕	桑田仁司, 臼井亮太, 菅原健二, 北本友佳, 杉崎和, 藤原周一, 渡邊好胤, 表孝徳, 安原章浩, 矢部大介, 黒瀬健, 清野裕	桑田仁司, 臼井亮太, 菅原健二, 北本友佳, 杉崎和, 藤原周一, 渡邊好胤, 表孝徳, 安原章浩, 矢部大介, 黒瀬健, 清野裕	シタグリプチン投与時のSU薬とメトホルミンの影響	シタグリプチン投与時のSU薬とメトホルミンの影響	シタグリプチン投与時のSU薬とメトホルミンの影響	糖尿病, 55, Suppl.1, S-256	糖尿病, 55, Suppl.1, S-256	糖尿病, 55, Suppl.1, S-256	2012/04	Japanese		Disclose to all
渡邊好胤, 黒瀬健, 菅原健二, 臼井亮太, 藤原周一, 北本友佳, 桑田仁司, 杉崎和, 表孝徳, 安原章浩, 矢部大介, 福島光夫, 清野裕	渡邊好胤, 黒瀬健, 菅原健二, 臼井亮太, 藤原周一, 北本友佳, 桑田仁司, 杉崎和, 表孝徳, 安原章浩, 矢部大介, 福島光夫, 清野裕	渡邊好胤, 黒瀬健, 菅原健二, 臼井亮太, 藤原周一, 北本友佳, 桑田仁司, 杉崎和, 表孝徳, 安原章浩, 矢部大介, 福島光夫, 清野裕	2型糖尿病患者におけるFMD値の検討について	2型糖尿病患者におけるFMD値の検討について	2型糖尿病患者におけるFMD値の検討について	糖尿病, 55, Suppl.1, S-318	糖尿病, 55, Suppl.1, S-318	糖尿病, 55, Suppl.1, S-318	2012/04	Japanese		Disclose to all
黒瀬健, 表孝徳, 渡邊好胤, 杉崎和, 北本友佳, 桑田仁司, 藤原周一, 臼井亮太, 菅原健二, 安原章浩, 矢部大介, 清野裕	黒瀬健, 表孝徳, 渡邊好胤, 杉崎和, 北本友佳, 桑田仁司, 藤原周一, 臼井亮太, 菅原健二, 安原章浩, 矢部大介, 清野裕		糖尿病と口腔ケア	糖尿病と口腔ケア		関西電力病院医学雑誌, 43, 1-2	関西電力病院医学雑誌, 43, 1-2	, 43, 1-2	2011	Japanese	Article, review, commentary, editorial, etc.(bulletin of university, research institution)	Disclose to all
<< < > >> Title language:

Conference Activities & Talks

Title	Title(Japanese)	Title(English)	Conference	Conference(Japanese)	Conference(English)	Date	Disclose
The role of the ER Ca2+ sensor, stromal interaction molecule 1 (STIM1), in GPR40-mediated potentiation of glucose-induced insulin secretion	The role of the ER Ca2+ sensor, stromal interaction molecule 1 (STIM1), in GPR40-mediated potentiation of glucose-induced insulin secretion	The role of the ER Ca2+ sensor, stromal interaction molecule 1 (STIM1), in GPR40-mediated potentiation of glucose-induced insulin secretion	54th Annual Meeting of European Association for the Study of Diabetes 2018	54th Annual Meeting of European Association for the Study of Diabetes 2018	54th Annual Meeting of European Association for the Study of Diabetes 2018	2018/10/01	Disclose to all
ER Ca2+ sensor, stromal interaction molecule 1 (STIM1) plays an important role in GPR40-mediated potentiation of glucose-induced insulin secretion	ER Ca2+ sensor, stromal interaction molecule 1 (STIM1) plays an important role in GPR40-mediated potentiation of glucose-induced insulin secretion	ER Ca2+ sensor, stromal interaction molecule 1 (STIM1) plays an important role in GPR40-mediated potentiation of glucose-induced insulin secretion	Asia Islet Biology & Incretin Symposium	Asia Islet Biology & Incretin Symposium	Asia Islet Biology & Incretin Symposium	2018/08/03	Disclose to all
ATP and Ca2+ dynamics in pancreatic β-cells: Ex vivo analysis using ATP biosensor GO-ATeam1	ATP and Ca2+ dynamics in pancreatic β-cells: Ex vivo analysis using ATP biosensor GO-ATeam1	ATP and Ca2+ dynamics in pancreatic β-cells: Ex vivo analysis using ATP biosensor GO-ATeam1	9th Scientific Meeting of the Asian Association for the Study of Diabetes	9th Scientific Meeting of the Asian Association for the Study of Diabetes	9th Scientific Meeting of the Asian Association for the Study of Diabetes	2017/05/20	Disclose to all
Long-term efficacy of GLP-1 receptor agonist liraglutide and remaining beta cell function: Retrospective analysis in Japanese patients with type 2 diabetes	Long-term efficacy of GLP-1 receptor agonist liraglutide and remaining beta cell function: Retrospective analysis in Japanese patients with type 2 diabetes	Long-term efficacy of GLP-1 receptor agonist liraglutide and remaining beta cell function: Retrospective analysis in Japanese patients with type 2 diabetes	Asia Islet Biology & Incretin Symposium	Asia Islet Biology & Incretin Symposium	Asia Islet Biology & Incretin Symposium	2013/11/07	Disclose to all
劇症1型糖尿病患者におけるグルカゴン分泌の検討	劇症1型糖尿病患者におけるグルカゴン分泌の検討		第14回日本内分泌学会近畿支部学術集会	第14回日本内分泌学会近畿支部学術集会		2013/10/19	Disclose to all
リラグルチド投与がインスリンおよびグルカゴン分泌に及ぼす影響の検討	リラグルチド投与がインスリンおよびグルカゴン分泌に及ぼす影響の検討		第56回糖尿病学会年次学術集会	第56回糖尿病学会年次学術集会		2013/05/17	Disclose to all
Insulin-to-Liraglutide switch in Japanese type 2 diabetes:Efficacy and clinical parameters for discontinuation due to hyperglycemia	Insulin-to-Liraglutide switch in Japanese type 2 diabetes:Efficacy and clinical parameters for discontinuation due to hyperglycemia.	Insulin-to-Liraglutide switch in Japanese type 2 diabetes:Efficacy and clinical parameters for discontinuation due to hyperglycemia	9th IDF-WPR Congress & 4th AASD Scientific Meeting	9th IDF-WPR Congress & 4th AASD Scientific Meeting	9th IDF-WPR Congress & 4th AASD Scientific Meeting	2012/11/27	Disclose to all
インスリンからリラグルチドへの変更時の効果及び注意点に関する検討	インスリンからリラグルチドへの変更時の効果及び注意点に関する検討		第55回日本糖尿病学会年次学術集会	第55回日本糖尿病学会年次学術集会		2012/05/17	Disclose to all
Efficacy and Safety of Insulin-to-Liraglutide Switch in Management of Type 2 Diabetes in Japanese	Efficacy and Safety of Insulin-to-Liraglutide Switch in Management of Type 2 Diabetes in Japanese	Efficacy and Safety of Insulin-to-Liraglutide Switch in Management of Type 2 Diabetes in Japanese	3rd Scientific Meeting of the Asian Association for the Study of Diabetes	3rd Scientific Meeting of the Asian Association for the Study of Diabetes	3rd Scientific Meeting of the Asian Association for the Study of Diabetes	2011/07/23	Disclose to all
Title language:

External funds: competitive funds and Grants-in-Aid for Scientific Research (Kakenhi)

Type	Position	Title(Japanese)	Title(English)	Period
研究活動スタート支援	Representative	膵β細胞における小胞体膜タンパクSTIMの意義の解明（2019年度分）		2019/04/01-2020/03/31

臼井 亮太

臼井亮太